FMO5 and endothelial dysfunction: Thus, inhibition of G6PD in vascular cells abrogated not only the over-activation of NADPH oxidase but also the subsequent exacerbated inflammation and endothelial dysfunction, which may help to explain a number of other experimental and clinical observations.